# A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity

> **NCT07232732** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 120 (estimated)

## Conditions studied

- Healthy
- Obesity
- Overweight

## Interventions

- **DRUG:** LY3549492

## Key facts

- **NCT ID:** NCT07232732
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07232732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07232732, "A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07232732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*